EGFR c.1636C>A ;(p.P546T)

Variant ID: 7-55231430-C-A

NM_005228.3(EGFR):c.1636C>A;(p.P546T)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.

British Journal Of Cancer
Gollins, Simon S; West, Nick N; Sebag-Montefiore, David D; Myint, Arthur Sun AS; Saunders, Mark M; Susnerwala, Shabbir S; Quirke, Phil P; Essapen, Sharadah S; Samuel, Leslie L; Sizer, Bruce B; Worlding, Jane J; Southward, Katie K; Hemmings, Gemma G; Tinkler-Hundal, Emma E; Taylor, Morag M; Bottomley, Daniel D; Chambers, Philip P; Lawrie, Emma E; Lopes, Andre A; Beare, Sandy S
Publication Date: 2017-10-24

Variant appearance in text: EGFR: 1636C>A
PubMed Link: 28859058
Variant Present in the following documents:
  • Main text
View BVdb publication page



Characterization of novel low passage primary and metastatic colorectal cancer cell lines.

Oncotarget
Boot, Arnoud A; van Eendenburg, Jaap J; Crobach, Stijn S; Ruano, Dina D; Speetjens, Frank F; Calame, Jan J; Oosting, Jan J; Morreau, Hans H; van Wezel, Tom T
Publication Date: 2016-03-22

Variant appearance in text: EGFR: 1636C>A
PubMed Link: 26894854
Variant Present in the following documents:
  • Main text
  • oncotarget-07-14499.pdf
View BVdb publication page